Revance Therapeutics | Modal Dan Cadangan

Equity Capital And Reserves Perubahan Tanggal
ALKERMES USD 1.36B 75.15M 2023-09
Eli Lilly USD 11.22B 156.6M 2023-09
Neurocrine Biosciences USD 2B 149.1M 2023-09
Pacira USD 870.13M 38.58M 2023-12
Supernus Pharmaceuticals USD 921.52M 9.32M 2023-12



Revance Therapeutics Modal Dan Cadangan - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Apr 2024.